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A B S T R A C T
The monitoring of emerging pollutants in wastewaters is nowadays an issue of special concern, with the classical
quantification methods being time and reagent consuming. In this sense, a FTIR transmission spectroscopy based
chemometric methodology was developed for the determination of eight of these pollutants. A total of 456
samples were, therefore, obtained, from an activated sludge wastewater treatment process spiked with the
studied pollutants, and analysed in the range of 200 cm−1 to 14,000 cm−1. Then, a k-nearest neighbour (kNN)
analysis aiming at identifying each sample pollutant was employed. Next, partial least squares (PLS) and or-
dinary least squares (OLS) modelling approaches were employed in order to obtain suitable prediction models.
This procedure resulted in good prediction abilities regarding the estimation of atrazine, desloratadine, para-
cetamol, β-estradiol, ibuprofen, carbamazepine, sulfamethoxazole and ethynylestradiol concentrations in was-
tewaters. These promising results suggest this technology as a fast, eco-friendly and reagent free alternative
methodology for the quantification of emerging pollutants in wastewaters.
1. Introduction
The monitoring of emerging pollutants in wastewaters is a subject
increasingly raising concern in the past few years. These compounds are
challenging in terms of quantification due to the low concentrations,
complex matrices and wide range of compounds with broad physical-
chemical properties (Fedorova et al., 2014). The typical traditional
methods applied to the quantification and monitoring of this class of
compounds include solid-phase extraction coupled to liquid chroma-
tography/tandem mass spectrometry (Li et al., 2018; Khan et al., 2012),
high-performance thin-layer chromatography (HPTLC) (Shewiyo et al.,
2012), and electrogenerated chemiluminescence biosensing methods
(Zhang et al., 2019). The disadvantages of these methods are well-
known and include being labour intensive, time and reagent consuming
with expensive in both equipment and reagents. In this context, simple,
reliable and rapid methods are needed to enable fast, reagent free,
sensitive, and selective determination of emerging pollutants.
Recently, several fast, accurate, eco-friendly and reagent free
methodologies based on infrared spectroscopy combined with chemo-
metric analysis have gained visibility with special focus in the phar-
maceutical industry (Noor et al., 2018). This technology is considered a
powerful non-invasive and non-destructive analytical technique that
allows measuring several parameters at once, being also sensitive to
both chemical and physical attributes (Puchert et al., 2011). Further-
more, these authors also highlight among its main advantages being a
green methodology, as it allows performing the analysis without the
addition of chemicals (reagents free technology). Despite all these ad-
vantages, the application of this technique to the quantification of
emerging pollutants in aqueous matrices is still a field under explora-
tion.
The presence of emerging pollutants, as pharmaceuticals, personal
care products, pesticides and others in aqueous systems occurs all over
the world. Fram and Belitz (2011) investigated the occurrence of
pharmaceutical compounds in groundwater used for public drinking-
water supply in California. These authors analysed 1231 samples of
groundwater and found pharmaceuticals compounds in 2.3 % of these
samples. The pharmaceuticals found in higher concentration were
paracetamol, caffeine, carbamazepine, codeine, p-xanthine, sulfa-
methoxazole, and trimethoprim. Moreover, pesticides and volatile or-
ganic compounds were also present in significant amounts in these
samples. Zhou et al. (2016) analysed twelve selected pharmaceuticals
including antibiotics, analgesics, antiepileptics and lipid regulators in
https://doi.org/10.1016/j.etap.2020.103458
Received 10 April 2020; Received in revised form 14 July 2020; Accepted 20 July 2020
⁎ Corresponding author.
E-mail address: cquintelas@deb.uminho.pt (C. Quintelas).
Environmental Toxicology and Pharmacology 80 (2020) 103458
Available online 22 July 2020
1382-6689/ © 2020 Elsevier B.V. All rights reserved.
T
water samples collected from 18 sampling sections along the three main
urban rivers in Yangpu District of Shanghai, China, and found a number
of emerging pollutants with relevant concentrations such as ibuprofen,
carbamazepine, salicylic acid, and azithromycin. The occurrence of
estrogens is also reported by several authors. Wang et al. (2015) ana-
lysed the occurrence and evaluated the ecological risk of five estrogens,
estrone, 17β-estradiol (E2), estriol, ethynylestradiol (EE2), and bi-
sphenol A in water, sediments and biota in Northern Taihu Lake
(China). The authors found that estrone, E2 and bisphenol A were
widely distributed in water, while estriol and EE2 were less frequently
detected. All the target estrogens were widely found in sediments and
biota.
Kosonen and Kronberg (2009) analysed the occurrence of anti-
histamines in sewage waters and in recipient rivers and found that three
compounds, cetirizine, acrivastine and fexofenadine were detected in
both influent and effluent wastewater samples at ng/L concentrations,
while loratadine, desloratadine and ebastine could not be detected in
the samples. As expected, the results showed that the level of anti-
histamines in wastewater is at the highest in Spring due to the outbreak
of allergic reactions caused by high plant pollen amounts in the air.
More recently, Kristofco and Brooks (2017) performed a global anti-
histamines survey in the environment, with special focus on the oc-
currence and hazards in aquatic systems. These authors analysed more
than one hundred literature papers, mainly from Asia-Pacific, European
and North American geographic regions, and found the occurrence of
24 antihistamines, including desloratadine, in water, sediment and
tissue. It is important to highlight that monitoring data from Africa and
South America was largely lacking, inferring that a larger number of
antihistamines occurrence is to be expected worldwide.
Herbicides are one of the emerging pollutants of concern. Despite
the fact that atrazine was banned in several countries, due to findings of
atrazine concentrations in ground and drinking waters exceeding leg-
islation values, monitoring of atrazine concentrations in the ground-
water since then provides information about the resilience of this
compound in groundwater (Vonberg et al., 2014). The monitoring data
obtained by these authors shows that even 20 years after the atrazine
ban, groundwater concentrations remain on a level close to the
threshold value of 0.1 μg L−1 without any considerable decrease.
Given the amount of information confirming the presence of
emerging pollutants in the environment, namely personal care pro-
ducts, antibiotics, antihistamines, sulphonamides, anticonvulsants, an-
algesic, antipyretic, pesticides and herbicides, among others, it is in-
creasingly important to develop fast, easy and green methods to
quantify its presence in aqueous systems. In this context, this study
focus on the determination of seven pharmaceutical compound con-
centrations, an antipyretic (paracetamol – PRC), an antihistamine (de-
sloratadine – DSL), an anti-inflammatory (ibuprofen – IBU), two es-
trogens (β-estradiol – E2, ethynylestradiol – EE2), an anticonvulsant
(carbamazepine – CRB), an antibiotic (sulfamethoxazole – SMX) and a
herbicide (atrazine – ATR), using Fourier-transform infrared (FTIR)
spectroscopy, in aqueous solutions. FTIR spectroscopy was already
tested for the determination of organic pollutants in wastewater: in
2004, Michel et al. (2004) developed a prototype mid-infrared sensor
system for the determination of organic pollutants, as trichloroethylene,
tetrachloroethylene and dichlorobenzene; more recently, Gowen et al.
(2012) analysed the state of the art for the application of vibrational
spectroscopy for analysis of water for human use and in aquatic eco-
systems and found that despite all the promising results proved by the
literature more works are need to performed before these techniques
can be implemented as water quality monitoring tools.
The quantification of pharmaceuticals in wastewaters by FTIR,
combined with chemometric analysis, represents a very promising fast,
eco-friendly and reagent free alternative to the traditional methods for
screening and estimation of emerging pollutants. To that effect, the
present report presents a new chemometric approach, based on partial
least squares (PLS) and ordinary least squares (OLS).
2. Materials and methods
2.1. Sample preparation
In batch biodegradation experiments, a 1.0 L glass beaker, con-
taining 0.3 L of activated sludge suspension (3 g L−1), was spiked with
different initial concentrations of emerging pollutants, namely deslor-
atadine (DSL), paracetamol (PRC), ibuprofen (IBU), β-estradiol (E2),
ethynylestradiol (EE2), carbamazepine (CRB), sulfamethoxazole (SMX)
and atrazine (ATR), within the range of mg L−1. Each solution was
prepared separately. The initial concentration of each assay is present,
as Supplementary Material, in Table S1. The experiments were per-
formed at room temperature and the agitation was kept constant at
150 rpm. A synthetic medium was fed to the system in the beginning of
each experiment accordingly with Quintelas et al. (2019). Aqueous
samples (1 mL) were taken at designated time intervals (within a 48 h
interval) and analysed by ultra-high-performance liquid chromato-
graphy (UHPLC).
2.2. UHPLC analysis
The chromatographic analysis was performed using a Shimadzu
Corporation apparatus (Tokyo, Japan) consisting of a UHPLC equipment
(Nexera) with one multi-channel pump (LC-30AD), an autosampler (SIL-
30AC), an oven (CTO-20AC), a diode array detector (M-20A) and a
system controller (CBM-20A) with built-in software (LabSolutions).
For the PRC quantification, a Kinetex2.6 u EVO C18 column
(150☓4.6mm i.d.) supplied by Phenomenex, Inc. (CA, USA) was used.
The mobile phase was 0.1 % phosphoric acid in water (pump A) and 0.1
% phosphoric acid in acetonitrile (pump B). Starting mobile phase
composition was 95 % A, decreased to 5% A in 9min, increased again
to 95 % (9.01 min) and remaining in this percentage for 3min. The flow
rate was 1.8 mL min−1. The samples were monitored by a diode array
detector from 190 to 400 nm, and chromatograms were extracted at
248 nm. Column oven was set at 50 °C and the injection volume was
5 μL.
For the ATR quantification, a Kinetex5 u EVO C18 column
(150☓4.6mm i.d.) supplied by Phenomenex, Inc. (CA, USA) was used.
The mobile phase was water (pump A) and acetonitrile (pump B). An
isocratic method was employed with 15 % A and 85 % B. The flow rate
was 1.0mL min−1. The samples were monitored by a diode array de-
tector from 190 to 400 nm, and chromatograms were extracted at
220 nm. Column oven was set at 25 °C and the injection volume was
30 μL.
The same column was used for the quantification of DSL, with a
mobile phase of potassium dihydrogen phosphate (0.05M; pH 3) (pump
A), acetonitrile (pump B) and methanol (pump C). An isocratic method
was employed with 45 % A, 48 % B and 7% C. The flow rate was 0.8mL
min−1. The samples were monitored by a diode array detector from 190
to 400 nm, and chromatograms were extracted at 247 nm. Column oven
was set at 25 °C and the injection volume was 12 μL.
The quantification of IBU, CRB, E2, EE2 and SMX concentrations was
performed accordingly to Quintelas et al. (2019). The standard errors
for the UHPLC measurements were 0.023mg L−1, 0.078mg L−1,
0.048mg L−1, 0.029mg L−1, 0.016mg L−1, 0.122mg L−1,
0.043mg L−1, and 0.077mg L−1, respectively for ATR, DSL, PRC, IBU,
SXF, CARB, EE2 and E2 and the values of R2 for the model (calibration)
curves were around 1 for all compounds.
2.3. Infrared scanning
The Fourier transform infrared (FTIR) spectra was recorded on a
FTIR/FT-NIR spectrometer (FTLA 2000, ABB, Thermo Electron
Corporation) equipped with an indium-gallium-arsenide (InGaAs) de-
tector, from 14,000 to 200 cm−1, in transmittance mode using a flow
cell with a 0.7mm pathlength. For each sample, 64 scans were made
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with a spectral resolution of 8 cm−1 and then averaged. Samples were
temperature equilibrated at 23 °C (during approximately 3min) in the
instrument before scanning. The integration time was adjusted until the
peaks at 8333–9091 cm−1 for FTIR were close to 60,000 intensity units.
Grams / AI software (Thermo Electron Corporation) was used for spec-
trometer configuration, control, and data acquisition. Distilled water
was used as background. A typical obtained FTIR spectrum (raw and
pre-processed with SNV, MSC, 1D and 2D) is presented as
Supplementary material (Figure S1).
2.4. Chemometric analyses
The ATR, DSL, IBU, CRB, SMX, E2, EE2 and PRC concentrations,
monitored throughout the different experiments time length, were used
as the Y dataset in the employed chemometric analyses, whilst the X
dataset consisted of the collected FTIR spectra (ranging from 14,000 to
200 cm−1). The following chemometric techniques were employed to
the dataset sequentially: i) k-nearest neighbour (kNN) analysis to allo-
cate each sample within its corresponding pollutant from the IR raw
dataset; ii) preprocessing of the FTIR raw dataset by means of standard
normal variate (SNV), multiplicative scatter correction (MSC), 1st de-
rivative (1D) and 2nd derivative (2D); and iii) partial least squares
(PLS) and ordinary least squares (OLS) modelling to obtain the pre-
dictive models regarding each studied pollutant.
2.4.1. k-nearest neighbour (kNN)
A k-nearest neighbour (kNN) analysis was next performed to the
entire X dataset (FTIR wavelengths values) in order to validate the
samples allocation within the corresponding studied pollutant. For that
purpose. one third of the preallocated samples was chosen as the (al-
location step) validation dataset, and the remaining two thirds as the
(allocation step) training samples. A total of 1000 random validation
and training (calibration) samples combinations were screened for ro-
bustness purposes. This methodology assumes that all samples corre-
spond to points in an n-dimensional space, with its nearest neighbours
defined in terms of the corresponding distance metric. Each sample
point of the (allocation step) validation dataset was next compared with
its three nearest neighbours in the training dataset, with the distance
metric being the Euclidean distance. Furthermore, the majority rule
was used to decide how to classify each validation sample point.
Further details regarding the kNN technique can be found in Cover and
Hart (1967) and Mitchell (1997).
2.4.2. Preprocessing of the IR raw dataset
Four different preprocessing methods were employed to the FTIR
raw dataset; standard normal variate (SNV), multiplicative scatter
correction (MSC), 1st derivative (1D) and 2nd derivative (2D). The SNV
was performed on each collected sample spectrum by mean centring
(removal of the spectrum average value), followed by scaling (division
by the spectrum standard deviation). Further details regarding the SNV
technique can be found in Barnes et al. (1989). The MSC was performed
by shifting and rotating each sample spectrum to fit, as close as pos-
sible, to the data average spectra. This was achieved by an ordinary
least squares first-degree polynomial, with the correction depending on
the entire dataset average spectra. Further details regarding the MSC
technique can be found in Martens and Naes (1989). Also 1st (1D) and
2nd (2D) derivatives were employed to the FTIR raw dataset. Each of
these preprocessing steps was then fed to the OLS methodology.
2.4.3. Ordinary (OLS) and partial (PLS) least squares regression
The OLS analysis is a linear least squares method for estimating
unknown parameters (Y data), from a set of explanatory variables (X
dataset), in a linear regression model. In this sense, the OLS calculates
the explanatory variables coefficients by minimizing the sum of the
residuals (differences between observed and predicted Y values)
squares in a given dataset. On the other hand, the PLS analysis
constructs latent variables (LVs) from the original X dataset in new (and
orthogonal) spaces, maximizing the captured predictive power of the X-
space with regard to the Y-space. Further details regarding the OLS and
PLS techniques can be found in Wold (1966) and Einax et al. (1997).
With the purpose of predicting the individual pollutants con-
centrations (Y data) from the FTIR wavelength dataset (X dataset), the
PLS analysis based methodology firstly employed standard normal
variate (SNV) and cross-validation (CV) tools to remove undesirable X
data matrix variations and test its predictive significance. Two different
methodologies were next employed: a) using the raw dataset [M1]; b)
using an iterative method by the arrangement of the wavelength values
according to weight similarity [M2]. The second methodology consisted
of the following sequential steps: i) determination of each wavelength
weights for the entire wavelength range in an initial PLS analysis; ii)
arrangement of the wavelength values according to weight similarity;
and iii) final PLS analysis with the averaged wavelength values. Both
methodologies are described further in Quintelas et al. (2019).
In addition, an OLS methodology was also employed to create a
linear model fit of the individual pollutant concentrations (Y data) from
the raw dataset OLS [raw] and the four different pre-processed FTIR,
namely SNV – OLS [SNV], MSC – OLS [MSC], 1D – OLS [1D] and 2D –
OLS [2D] data (X datasets). A forward selection method was employed
for the choice of the selected wavelengths, selecting the best variable
first, next finding the second best, and so on until the obtained model
ceased to improve or reached the maximum number of components
allowed. Care was taken to accept solely results with probability values
(p-values) for all coefficients (including the intercept) below 0.05, that
is, statistically significant for a level of significance (α) of 0.05.
A total of 5000 PLS and OLS possible random validation and
training (calibration) samples combinations, for each employed meth-
odology and dataset, were screened to select the most unbiased training
and validation datasets (regarding the calibration step). During this
iterative procedure, the samples were randomly divided into two
groups, the training set with two thirds of the samples, and the (ex-
ternal) validation set with the remaining one third of the samples in
each iteration. The internal model validation was performed by cross-
validation with the training dataset.
The conducted study was conducted in a twofold manner in order to
i) strictly obey to the ASTM E1655 (2012) standard regarding the
training (calibration) dataset or ii) obey to the ASTM E1655 standard
considering the global (training and validation) dataset rather than
solely the training (calibration) dataset. This standard recommends that
the number of model components (k) should be no larger than one sixth
of the number of calibration samples (n) [n>6 (k + 1)]. In ac-
cordance, whereas the first procedure resulted in a set of model para-
meters (wavelengths or PLS components) up to one sixth of the training
samples alone (designated as procedure 1 – [P1]), the later resulted in a
set of parameters up to one sixth of the global (training and validation)
samples (designated as procedure 2 – [P2]), for each pollutant. The root
mean square error (RMSE) value was used to define the best set of
parameters following the above conditions.
All the above analyses were performed in Matlab 7.11 (The
Mathworks, Inc. Natick, USA).
3. Results and discussion
3.1. Analytical data
The concentrations minimum, maximum, range and standard de-
viation (STD) values, number of samples in the training and validation
sets, and number of model components in P1 and P2 procedures, for
desloratadine (DSL), paracetamol (PRC), ibuprofen (IBU), β-estradiol
(E2), ethynylestradiol (EE2), carbamazepine (CRB), sulfamethoxazole
(SMX) and atrazine (ATR), in the experiments are presented in Table 1.
A total of 456 samples were initially collected, 60 samples for each
pollutant, with the exception of IBU with 36 samples. From this initial
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dataset, the samples presenting a concentration bellow the analytical
instrumentation sensitivity level were discarded, resulting in a final set
of 435 samples. The samples were then divided into two groups, the
training set, with two thirds of the samples, and the validation set, with
the remaining one third of the samples.
3.2. kNN results
In order to allow the concentration prediction by individually tai-
lored PLS and OLS analyses, first the collected FTIR data was subjected
to a k-nearest neighbour (kNN) analysis with the aim of identifying
each dataset sample within the corresponding studied pollutant. For
that purpose, the entire FTIR wavelength dataset was used for a total of
1000 random validation and training (calibration) sets, representing
the samples allocation step. This resulted in a global identification
percentage, for the allocation step validation dataset, of 98.6 % with
solely 1.4 % of the samples misclassified, a figure is presented as
Supplementary material (Figure S2).
Therefore, and given the high identification ability for each studied
pollutant obtained by the kNN analysis, regarding the allocation step
validation dataset, it could be concluded that, upon this step, individual
PLS and OLS analyses could be performed to model each pollutant
concentration. It should be emphasized, however, that the employed
emerging pollutants identification methodology was only tested for the
case where solely one of the studied pollutants was present in a sample.
Further extension to samples presenting two or more of the studied
emerging pollutants should yet be studied.
3.3. PLS and OLS results
For each method (OLS [raw], OLS [SNV], OLS [MSC], OLS [1D],
OLS [2D], PLS [M1] and PLS [M2]) and studied pollutant, the regres-
sion equation, coefficient of determination (R2), number of FTIR wa-
velengths (λ), number of PLS components, root mean square error
(RMSE, in percentage of the studied range) and residual predictive
deviation (RPD) values were determined. Table 2 presents the obtained
results for a maximum number of model parameters (wavelengths or
PLS components) up to one sixth of the training samples alone [P1],
whereas Table 3 presents the obtained results for a maximum of up to
one sixth of the global (training and validation) dataset [P2], for each
pollutant.
The regression equation and R2 values are presented for the global
(training+ validation) dataset, whereas the RMSE and RPD are pre-
sented both for the global dataset and for the validation dataset. An
RPD parameter, i.e. the ratio between the population standard devia-
tion (SD) and the prediction standard error of cross validation (SECV),
larger than 3 is recommended for screening purposes (Fearn, 2002).
The first methodology employed for modelling the pharmaceuticals
concentrations was the PLS analysis using both the raw dataset [M1]
and the iterative method [M2]. The analysis of the prediction ability,
revealed that the pollutants that presented RPD values above 3, were
the ATR, CRB and IBU for the [M1] methodology and the ATR, DSL,
CRB and IBU for the [M2] methodology, both for the global
(training+ validation) and validation datasets. Comparing these two
methodologies, the best results (higher R2 and RPD, and lower RMSE
values) were obtained by the [M2] methodology for the ATR (R2 of
0.989), DSL (R2 of 0.912) and CRB (R2 of 0.962), and by the [M1]
methodology for the IBU (R2 of 0.988) prediction. Care should be taken,
however, when analysing the IBU results given that the [M2] metho-
dology failed to go beyond the third PLS component, whereas the [M1]
results were obtained by the use of four PLS components.
Under the P1 procedure, the PLS based methodologies allowed for
an adequate prediction of half of the studied pharmaceuticals, with
RMSE % values ranging from under 2% (ATR) to just below 7.5 %
(DSL), and from just above 2% (ATR) to slightly under 8.5 % (DSL), for
the global and validation datasets respectively. Furthermore, the [M2]
methodology resulted, in most cases, in best prediction abilities than
the [M1] methodology, proving its value, regarding the classical PLS
[M1], facing a reduced set of components.
Regarding the OLS methodology, apart from the use of the raw
dataset, OLS [raw], four different X datasets preprocessing methodol-
ogies were employed, namely the standard normal variate, OLS [SNV],
multiplicative scatter correction, OLS [MSC], 1st derivative, OLS [1D]
and 2nd derivative, OLS [2D]. The analysis of the prediction ability,
revealed that the pharmaceuticals that presented RPD values above 3,
were the ATR, PRC and CRB for the [raw], the ATR and DSL for the
[SNV], the ATR, PRC and CRB for the [MSC], the ATR, PRC, E2 and CRB
for the [1D] and the ATR, PRC, E2 and CRB for the [2D] methodologies,
both for the global (training+ validation) and validation datasets (with
the exception of E2 for [1D] regarding the validation dataset).
Comparing these five methodologies, the best results (higher R2 and
RPD, and lower RMSE values) were obtained by the [SNV] metho-
dology for the DSL (R2 of 0.898), by the [1D] methodology for the ATR
(R2 of 0.991) and by the [2D] methodology for the PRC (R2 of 0.976),
E2 (R2 of 0.933) and CRB (R2 of 0.968) predictions.
Under the P1 procedure, the OLS based methodologies allowed for
an adequate prediction of five of the studied pharmaceuticals, with
RMSE % values ranging from under 2% (ATR) to just under 8% (DSL),
and from 1.5 % (ATR) to slightly above 8.5 % (E2), for the global and
validation datasets respectively. Furthermore, the [2D] methodology
emerged as the one presenting the best prediction abilities wthin the
OLS based methodologies facing a reduced set of components.
Taking into account both the PLS and OLS based methodologies, the
IBU and DSL were best predicted by the PLS, and the ATR, PRC, E2 and
CRB by the OLS, under the P1 procedure. However, two of the studied
pharmaceuticals, namely EE2 and SMX failed to be adequatelly pre-
dicted by this procedure, not surpassing an R2 of 0.649 and 0.787, and
an RPD (for the global dataset) of 1.77 and 2.88, respectively.
With the increase of the PLS and OLS model components, a general
increase in the prediction ability occurred, as could be expected.
However, it was observed that the adequateness of the different
methodologies varied quite differently among each other.
Table 1
Minimum, maximum, range, standard deviation (STD), number of samples in the training and validation sets and number of model components in P1 and P2









training set validation set P1 comp. P2 comp.
ATR 1.17 19.30 18.13 3.41 40 20 7 10
DSL 0.68 5.51 4.83 1.24 30 14 5 7
PRC 0.29 9.01 8.72 2.24 38 19 6 10
E2 0.09 2.75 2.67 0.79 39 19 7 10
EE2 0.44 6.93 6.50 1.86 40 20 7 10
CRB 0.56 8.12 7.56 2.10 40 20 7 10
IBU 0.00 1.99 1.98 0.45 24 12 4 6
SMX 0.31 7.60 7.29 1.58 40 20 7 10
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The analysis of the PLS prediction ability, revealed that all the
pharmaceuticals presented RPD values above 3 for the [M1] metho-
dology (except for the validation dataset for the DSL) whereas the EE2
failed to achieve that goal regarding the [M2] methodology, both for
the global (training+ validation) and validation datasets. Comparing
these two methodologies, the best results (higher R2 and RPD, and
lower RMSE values) were obtained by the [M2] methodology for the
ATR (R2 of 0.996), DSL (R2 of 0.989) and CRB (R2 of 0.962), and by the
[M1] methodology for the PRC (R2 of 0.989), E2 (R2 of 0.965), EE2 (R2
of 0.917), IBU (R2 of 0.996) and SMX (R2 of 0.978) predictions. Again,
care should be taken when analysing the IBU results given that the
[M2] methodology failed to go beyond the third PLS component,
whereas the [M1] results were obtained by the use of six PLS compo-
nents.
Under the P2 procedure, the PLS based methodologies allowed for
an adequate prediction of all of the studied pharmaceuticals, with
RMSE % values ranging from slightly above 1% (ATR) to 5.5 % (E2),
and from just above 0.5 % (IBU) to slightly under 9.5 % (EE2), for the
global and validation datasets respectively. Furthermore, and contrary
to the P1 procedure, the [M1] methodology resulted, in most cases, in
best prediction abilities than the [M2] methodology.
With respect to the OLS methodology prediction ability, the phar-
maceuticals that presented RPD values above 3 were the ATR, PRC, CRB
and SMX for the [raw], the ATR and DSL for the [SNV], the ATR, PRC,
Table 2
Regression equation, R2, FTIR wavelengths (λ), PLS components, RMSE and RPD values for each studied pollutant and P1 procedure (glb – global and val –
validation).
Regression glb R2 glb # IR λ # PLS comp RMSE glb % RMSE val % RPD glb RPD val
ATR PLS [M1] y= 0.976 x 0.943 7 4.42 4.29 4.25 4.38
PLS [M2] y= 0.994 x 0.989 7 1.97 2.18 9.56 8.60
OLS [raw] y= 0.993 x 0.984 7 2.35 1.50 8.00 12.56
OLS [SNV] y= 0.963 x 0.917 7 5.29 6.05 3.55 3.11
OLS [MSC] y= 0.990 x 0.984 7 2.36 1.78 7.95 10.55
OLS [1D] y= 0.993 x 0.991 7 1.73 1.52 10.87 12.38
OLS [2D] y= 0.989 x 0.989 7 1.94 1.94 9.69 9.66
DSL PLS [M1] y= 0.846 x 0.730 5 12.83 16.12 2.00 1.59
PLS [M2] y= 0.953 x 0.912 5 7.39 8.32 3.47 3.08
OLS [raw] y= 0.866 x 0.727 5 12.17 14.66 2.11 1.75
OLS [SNV] y= 0.951 x 0.898 5 7.95 8.28 3.23 3.10
OLS [MSC] y= 0.883 x 0.762 5 11.99 12.97 2.14 1.98
OLS [1D] y= 0.884 x 0.852 5 9.77 14.26 2.63 1.80
OLS [2D] y= 0.901 x 0.841 5 9.98 12.82 2.57 2.00
PRC PLS [M1] y= 0.930 x 0.864 6 9.42 10.21 2.73 2.52
PLS [M2] y= 0.847 x 0.546 6 15.54 16.28 1.66 1.58
OLS [raw] y= 0.966 x 0.953 6 5.51 5.75 4.67 4.47
OLS [SNV] y= 0.867 x 0.695 6 13.12 12.30 1.96 2.09
OLS [MSC] y= 0.961 x 0.954 6 5.58 5.32 4.61 4.83
OLS [1D] y= 0.970 x 0.966 6 4.78 3.49 5.38 7.37
OLS [2D] y= 0.981 x 0.976 6 4.03 3.12 6.38 8.23
E2 PLS [M1] y= 0.905 x 0.858 7 10.97 13.80 2.69 2.13
PLS [M2] y= 0.918 x 0.762 7 12.73 17.24 2.31 1.71
OLS [raw] y= 0.910 x 0.799 7 12.23 13.83 2.41 2.13
OLS [SNV] y= 0.922 x 0.866 7 10.63 10.17 2.77 2.90
OLS [MSC] y= 0.903 x 0.822 7 12.40 14.60 2.38 2.02
OLS [1D] y= 0.942 x 0.918 7 8.40 10.09 3.51 2.92
OLS [2D] y= 0.955 x 0.933 7 7.53 8.62 3.91 3.42
EE2 PLS [M1] y= 0.848 x 0.549 7 16.63 19.78 1.72 1.45
PLS [M2] y= 0.855 x 0.649 7 16.18 21.98 1.77 1.30
OLS [raw] y= 0.814 x 0.488 7 18.58 21.63 1.54 1.32
OLS [SNV] y= 0.808 x 0.535 7 18.54 28.22 1.55 1.02
OLS [MSC] y= 0.817 x 0.478 7 18.67 23.00 1.53 1.25
OLS [1D] y= 0.850 x 0.611 7 16.39 19.07 1.75 1.50
OLS [2D] y= 0.817 x 0.547 7 17.67 24.74 1.62 1.16
CRB PLS [M1] y= 0.964 x 0.960 7 5.70 7.11 4.87 3.90
PLS [M2] y= 0.984 x 0.962 7 5.30 4.92 5.24 5.64
OLS [raw] y= 0.965 x 0.947 7 6.39 7.37 4.34 3.76
OLS [SNV] y= 0.910 x 0.774 7 12.14 16.59 2.29 1.67
OLS [MSC] y= 0.961 x 0.947 7 6.46 7.73 4.30 3.59
OLS [1D] y= 0.965 x 0.960 7 5.66 6.98 4.90 3.97
OLS [2D] y= 0.971 x 0.968 7 4.98 4.98 5.57 5.58
IBU PLS [M1] y= 0.9599 x 0.988 4 2.62 2.72 8.72 8.40
PLS [M2] y= 0.886 x 0.927 3 6.32 6.32 3.61 3.61
OLS [raw] y= 0.678 x 0.689 4 12.69 14.63 1.80 1.56
OLS [SNV] y= 0.654 x 0.680 4 12.86 15.18 1.77 1.50
OLS [MSC] y= 0.678 x 0.670 4 12.70 14.60 1.80 1.56
OLS [1D] y= 0.811 x 0.760 4 10.65 5.53 2.14 4.13
OLS [2D] y= 0.625 x 0.653 4 13.47 16.13 1.70 1.42
SMX PLS [M1] y= 0.921 x 0.782 7 9.31 9.70 2.32 2.23
PLS [M2] y= 0.933 x 0.876 7 7.51 8.63 2.88 2.51
OLS [raw] y= 0.907 x 0.815 7 9.00 11.52 2.41 1.88
OLS [SNV] y= 0.915 x 0.698 7 10.80 13.43 2.00 1.61
OLS [MSC] y= 0.902 x 0.810 7 9.14 11.38 2.37 1.90
OLS [1D] y= 0.933 x 0.854 7 8.04 10.12 2.69 2.14
OLS [2D] y= 0.934 x 0.854 7 8.02 9.44 2.70 2.29
* In all cases the obtained model p-value was below 0.001.
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CRB and SMX for the [MSC], all but the EE2 (and the SMX validation
dataset) for the [1D] and all but the EE2 and IBU for the [2D] meth-
odologies, both for the global (training+ validation) and validation
datasets. Comparing these five methodologies, the best results (higher
R2 and RPD, and lower RMSE values) were obtained by the [1D]
methodology for the ATR (R2 of 0.995), DSL (R2 of 0.937) and IBU (R2
of 0.904) and by the [2D] methodology for the PRC (R2 of 0.989), E2
(R2 of 0.965), CRB (R2 of 0.981) and SMX (R2 of 0.918) predictions.
Under the P2 procedure, the OLS based methodologies allowed for
an adequate prediction of of all of the studied pharmaceuticals with the
exception of EE2, with RMSE % values ranging from just under 1.5 %
(ATR) to slightly above 7% (IBU), and from slighly above 1% (ATR) to
just under 7% (DSL), for the global and validation datasets respectively.
Furthermore, both the [1D] and the [2D] methodologies emerged as the
ones presenting the best prediction abilities wthin the OLS based
methodologies, somewhat in line with the P1 procedure.
Taking into account both the PLS and OLS based methodologies, all
but the PRC (and the ATR and E2 regarding the validation dataset),
were best predicted by the PLS, under the P2 procedure. This result is
significantly different from the one obtained under the P1 procedure
(with the majority of the pharmaceuticals being best predicted by the
OLS methodology). It seems, thus, that the increase in the allowable
number of components leads to a greater performance increase for the
PLS based methodologies. On the other hand, a more restrictive number
Table 3
Regression equation, R2, FTIR wavelengths (λ), PLS components, RMSE and RPD values for each studied pollutant and P2 procedure (glb – global and val –
validation).
Regression glb R2 glb # IR λ # PLS comp RMSE glb % RMSE val % RPD glb RPD val
ATR PLS [M1] y= 0.992 x 0.985 10 2.30 2.67 8.17 7.04
PLS [M2] y= 0.994 x 0.996 10 1.14 1.30 16.49 14.42
OLS [raw] y= 0.996 x 0.990 10 1.87 1.61 10.02 11.67
OLS [SNV] y= 0.987 x 0.947 10 4.24 4.53 4.44 4.15
OLS [MSC] y= 0.995 x 0.990 10 1.86 1.44 10.08 13.08
OLS [1D] y= 0.998 x 0.995 10 1.33 1.31 14.13 14.29
OLS [2D] y= 0.994 x 0.994 10 1.40 1.17 13.40 16.10
DSL PLS [M1] y= 0.919 x 0.900 7 8.11 11.35 3.16 2.26
PLS [M2] y= 0.987 x 0.989 7 2.67 1.97 9.62 13.03
OLS [raw] y= 0.906 x 0.853 7 9.57 11.34 2.68 2.26
OLS [SNV] y= 0.961 x 0.927 7 6.67 6.86 3.85 3.74
OLS [MSC] y= 0.902 x 0.849 7 9.60 9.94 2.67 2.58
OLS [1D] y= 0.952 x 0.937 7 6.45 8.12 3.98 3.16
OLS [2D] y= 0.951 x 0.926 7 6.89 8.19 3.73 3.13
PRC PLS [M1] y= 0.995 x 0.989 10 2.59 2.92 9.95 8.81
PLS [M2] y= 0.977 x 0.963 10 5.02 6.02 5.13 4.27
OLS [raw] y= 1.000 x 0.985 10 3.18 3.58 8.09 7.19
OLS [SNV] y= 0.913 x 0.855 10 10.18 12.28 2.53 2.09
OLS [MSC] y= 0.984 x 0.980 10 3.67 3.83 7.01 6.71
OLS [1D] y= 0.984 x 0.984 10 3.24 3.49 7.94 7.37
OLS [2D] y= 0.987 x 0.989 10 2.70 3.13 9.51 8.22
E2 PLS [M1] y= 0.976 x 0.965 10 5.45 5.50 5.41 5.36
PLS [M2] y= 0.950 x 0.939 10 7.27 8.48 4.05 3.48
OLS [raw] y= 0.939 x 0.877 10 10.02 11.20 2.94 2.63
OLS [SNV] y= 0.942 x 0.913 10 8.47 8.83 3.48 3.34
OLS [MSC] y= 0.944 x 0.880 10 9.89 9.38 2.98 3.14
OLS [1D] y= 0.959 x 0.960 10 6.00 6.50 4.91 4.53
OLS [2D] y= 0.972 x 0.965 10 5.47 4.86 5.38 6.07
EE2 PLS [M1] y= 0.933 x 0.917 10 8.32 9.30 3.44 3.08
PLS [M2] y= 0.947 x 0.809 10 11.69 12.79 2.45 2.24
OLS [raw] y= 0.873 x 0.719 10 12.80 18.01 2.24 1.59
OLS [SNV] y= 0.893 x 0.662 10 15.34 18.12 1.87 1.58
OLS [MSC] y= 0.891 x 0.708 10 14.11 19.21 2.03 1.49
OLS [1D] y= 0.910 x 0.797 10 12.10 13.72 2.37 2.09
OLS [2D] y= 0.907 x 0.813 10 12.08 14.42 2.37 1.99
CRB PLS [M1] y= 0.969 x 0.962 10 5.54 7.26 5.01 3.82
PLS [M2] y= 1.001 x 0.991 10 2.61 3.57 10.63 7.76
OLS [raw] y= 0.994 x 0.960 10 5.44 6.11 5.10 4.54
OLS [SNV] y= 0.947 x 0.853 10 10.11 13.35 2.74 2.08
OLS [MSC] y= 0.983 x 0.962 10 5.37 7.42 5.16 3.74
OLS [1D] y= 0.975 x 0.971 10 4.69 5.74 5.91 4.84
OLS [2D] y= 0.979 x 0.981 10 3.87 4.39 7.16 6.32
IBU PLS [M1] y= 0.988 x 0.996 10 1.43 0.55 15.99 41.42
PLS [M2] y= 0.886 x 0.927 3 6.32 6.32 3.61 3.61
OLS [raw] y= 0.836 x 0.861 6 8.52 9.57 2.68 2.39
OLS [SNV] y= 0.788 x 0.825 6 9.45 10.96 2.42 2.08
OLS [MSC] y= 0.838 x 0.862 6 8.43 6.20 2.71 3.68
OLS [1D] y= 0.880 x 0.904 6 7.10 5.91 3.21 3.86
OLS [2D] y= 0.806 x 0.836 6 9.24 9.09 2.47 2.51
SMX PLS [M1] y= 0.984 x 0.978 10 3.18 2.84 6.80 7.61
PLS [M2] y= 0.959 x 0.953 10 4.80 7.16 4.51 3.02
OLS [raw] y= 0.942 x 0.912 10 6.78 6.92 3.19 3.13
OLS [SNV] y= 0.900 x 0.794 10 9.46 13.33 2.29 1.62
OLS [MSC] y= 0.951 x 0.904 10 6.52 6.50 3.32 3.33
OLS [1D] y= 0.954 x 0.916 10 6.23 7.73 3.47 2.80
OLS [2D] y= 0.955 x 0.918 10 6.06 6.39 3.57 3.39
* In all cases the obtained model p-value was below 0.001.
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of components seems to favor the use of OLS based methodlogies.
With an increased number of components, concerns may rise on
possible overfitting of the prediction model to the training dataset.
However, analysing the RMSE values for both the global and the vali-
dation dataset regarding the best models, no significant differences
were found, with an average global RMSE to validation RMSE ratio of
1.059 for the P1 procedure and of 1.061 for the P2 procedure (resulting
in a 6% difference). Given that the increased number of components in
the P2 procedure led to better prediction abilities (average R2 of 0.978,
global RMSE % of 3.72 % and validation RMSE % of 3.94 % for the P2
and of 0.912, 6.50 % and 7.49 % for the P1, regarding the entire
pharmaceuticals dataset), and seemed to be unaffected by overfitting
problems, the P2 methodlogy results were chosen as the best prediction
models.
Hence, these model results for the ATR, DSL, PRC, E2, EE2, CRB, IBU
and SMX predictions, encompassing both the training (orange circles)
and validation (grey circles) data are presented in Fig. 1.
Regarding the PLS models, each individual PLS component (or la-
tent variable) results from a linear combination of the whole set of
wavelengths. Therefore, and although the weight of each wavelength
for a given PLS latent variable is different, no individual wavelength
can be attributed to it.
Fig. 1. Best model results for the ATR, DSL, PRC, E2, EE2, CRB, IBU and SMX predictions. The orange circles represent the training data and the gray circles represent
the validation data.
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In contrast, the employed wavelengths by the best OLS models
varied from pharmaceutical to pharmaceutical, comprising, in en-
semble, an IR region spanning from the 7200 to 200 cm−1. The region
that was most used by the prediction models was the 2000 to 200 cm−1
(39.7 % of the wavelengths), followed by the 4000 to 2000 cm−1 and
6000 to 4000 cm−1 (23.3 % and 24.7 % of the used wavelengths, re-
spectively). These regions encompass the absorption frequency of the
studied pharmaceuticals main chemical bonds (CeC, C]C, C–H, CH2,
CH3, CeO, C]O, CeN, C]N, CeCl, C–S, OeH, NeH, S]O and aro-
matic rings), as well as their combinations and first overtones.
On the other hand, the studied pharmaceutical compounds present
IR characteristic wavelength bands in the regions of 500 to 1750 cm−1
and of 2750 to 3500 cm−1, when analyzed as pure substances. Indeed,
57.5 % of the used wavelengths in the best models fell below
3500 cm−1. It should be stressed, however, that these pollutants were
not studied as pure substances but diluted in a quite complex matrix
(wastewater). In this sense, a diversity of other compounds present IR
characteristic bands that partially overlap some of the studied phar-
maceuticals bands. In accordance, and in order to the models to assess
the studied pharmaceutical weight for its corresponding bands and the
weight of other (interference) compounds, a larger set of wavelengths
(comprising information of the interference compounds) must be em-
ployed. Indeed, the importance of these added wavelengths in the best
models can be proven by the prediction ability improvement from the
P1 procedure to the P2 procedure.
3.4. Remarks and perspective
The application of FTIR techniques combined with chemometrics is
not new and has been used by the pharmaceutical industry for different
purposes as to thoroughly understand the feeding and mixing steps in
the continuous manufacturing of solid oral dosage forms (Vargas et al.,
2018), continuous blend potency determination in the feed frame of a
tablet press (De Leersnyder et al., 2018), in-line and real-time mon-
itoring of pharmaceutical hot melt extrusion (Vo et al., 2018) and as an
analytical technique (Eldin and Shalaby, 2011; Said et al., 2011).
However, all these works focus in the evaluation and determination in
solid matrices and only a few papers described the quantification of
pharmaceuticals in other matrices as syrup, suspensions, creams and
ointments (Ziémons et al., 2010; Silva et al., 2012; Schlegel et al.,
2017). Also, the analysis of herbicide residues applied in the soil, and in
particular the presence of imazapyr, has already been quantified using
near-infrared spectroscopy (NIRS) coupled to a chemometrics approach
(Soto-Barajas et al., 2012), but, again, no data has been found for the
quantification of herbicides in aqueous matrices by NIR.
Nowadays, FTIR techniques are becoming widespread in monitoring
wastewater treatment processes. Several parameters can be measured
with this technique as alcohols and volatile organic acids (Nespeca
et al., 2017), biogas production (Stockl and Lichti, 2018), biochemical
oxygen demand, chemical oxygen demand (COD), turbidity, total or-
ganic carbon (TOC) and volatile fatty acids (VFA), among others
(Mesquita et al., 2017). On the other hand, the quantification of
pharmaceuticals, and other emerging pollutants, in wastewaters by
FTIR and chemometrics is just starting to have the attention of the
scientific community (Quintelas et al., 2019). Indeed, more work is still
needed to explore this technique and to improve the developed models.
The occurrence of emerging or newly identified contaminants, as
pharmaceutical compounds and herbicides, in the water resources is of
continued concern for the health and safety of the community. In this
context, the approach described in the present report proposes an eco-
friendly and economically viable technology able to solve these pro-
blems.
4. Conclusions
Based on FTIR transmission spectroscopy spectra, a chemometric
approach was developed for the quantification of emerging pollutants
in wastewaters. In accordance, two partial least squares (PLS) and five
ordinary least squares (OLS) modelling approaches were employed. The
prior use of a k-nearest neighbour (kNN) analysis, aiming at validating
the samples allocation within the corresponding studied pollutant, in
order to allow the concentration prediction by individually tailored PLS
and OLS analyses, allowed for the correct identification of 97.2 % of the
samples with solely 2.8 % of the samples misclassified.
The procedure limiting the number of OLS and PLS model compo-
nents to an upmost of one sixth of the number of calibration samples,
led to adequate prediction abilities for the quantification of atrazine,
desloratadine, paracetamol, β-estradiol, ibuprofen and carbamazepine.
Under this procedure, the OLS based methodologies outperformed the
PLS based methodologies for four of the above pharmaceuticals. The
second procedure limiting the number of OLS and PLS model compo-
nents to an upmost of one sixth of the number of global (calibra-
tion+ validation) samples, led to adequate prediction abilities for the
entire set of studied pharmaceuticals, including the ethynylestradiol
and sulfamethoxazole. Under this procedure, all but the PRC were best
predicted by the PLS. This later procedure allowed for better prediction
abilities whuilst remaninig unaffected by overfitting problems.
In conclusion, this methodology can be considered as promising
towards a future replacement of UHPLC and GC analysis for the routine
quantification of emerging pollutants in wastewaters, representing
presently a fast, eco-friendly and reagent free technique for pharma-
ceuticals screening and estimation in wastewaters. Indeed, the pro-
posed method is a simpler, reagents free and faster technique pre-
senting, at the same time, a high prediction ability for the
quantification of atrazine, desloratadine, paracetamol, β-estradiol,
ibuprofen, carbamazepine and sulfamethoxazole and slightly lower for
the ethynylestradiol. It should be underlined, however, that the em-
ployed emerging pollutants identification methodology was only tested
for the case where solely one of the studied pollutants was present in a
sample. Further extension to samples presenting two or more of the
studied emerging pollutants should yet be studied.
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